You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Monatide (IMS 3015)

Showing 1 - 25 of 77
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Colo-rectal Cancer Trial (biological, drug, procedure)

Not yet recruiting
  • Colo-rectal Cancer
  • Recombinant Human EGF-rP64K/Montanide ISA 51 Vaccine
  • +8 more
  • (no location specified)
Aug 28, 2023

Melanoma Trial in New York (DC Vaccine, Montanide Vaccine, Poly-ICLC)

Completed
  • Melanoma
  • DC Vaccine
  • +2 more
  • New York, New York
  • +1 more
Sep 13, 2022

Melanoma (Skin) Trial in Tampa (MART-1, NY-ESO-1, gp100:209-217(210M))

Completed
  • Melanoma (Skin)
  • MART-1
  • +5 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Jan 17, 2023

Triple Negative Breast Cancer, Breast Tumors Trial in Fayetteville, Little Rock (P10s-PADRE with MONTANIDE™ ISA 51 VG +

Active, not recruiting
  • Triple Negative Breast Cancer
  • Breast Neoplasms
  • P10s-PADRE with MONTANIDE™ ISA 51 VG + Doxorubicin + Cyclophosphamide + Paclitaxel
  • Doxorubicin + Cyclophosphamide + Paclitaxel
  • Fayetteville, Arkansas
  • +1 more
Aug 18, 2022

Chronic Lymphocytic Leukemia Trial in Herlev (PD-L1, PD-L2 peptides with Montanide ISA51)

Completed
  • Chronic Lymphocytic Leukemia
  • PD-L1, PD-L2 peptides with Montanide ISA51
  • Herlev, Denmark
    Herlev Hospital
Feb 4, 2022

Partial Response of Multiple Myeloma or Plasma Cell Leukemia, Plasma Cell Myeloma Trial in Buffalo, Rochester (biological,

Active, not recruiting
  • Partial Response of Multiple Myeloma or Plasma Cell Leukemia
  • Plasma Cell Myeloma
  • Incomplete Freund's Adjuvant
  • +4 more
  • Buffalo, New York
  • +1 more
Dec 12, 2022

COPD, Lung Non-Small Cell Carcinoma, Pneumonia Trial in Buffalo (Quality-of-Life Assessment, Questionnaire Administration,

Recruiting
  • Chronic Obstructive Pulmonary Disease
  • +7 more
  • Quality-of-Life Assessment
  • +2 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Oct 20, 2022

Melanoma (Skin) Trial in Tampa (biological, drug, procedure)

Active, not recruiting
  • Melanoma (Skin)
  • NY-ESO-1 157-165 (165V)
  • +5 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Jan 17, 2023

Non Small Cell Lung Cancer Trial in Leiden, Rotterdam (TEIPP24 (LRPAP7-30V-SLP vaccine in Montanide ISA-51))

Recruiting
  • Non Small Cell Lung Cancer
  • TEIPP24 (LRPAP7-30V-SLP vaccine in Montanide ISA-51)
  • Leiden, Zuid-Holland, Netherlands
  • +1 more
Jun 1, 2023

Breast Cancer, Breast Tumors Trial in Fayetteville, Little Rock (Chemovax - P10s-PADRE/ MONTANIDE™ ISA 51 VG + Doxorubicin +

Completed
  • Breast Cancer
  • Breast Neoplasms
  • Chemovax - P10s-PADRE/ MONTANIDE™ ISA 51 VG + Doxorubicin + Cyclophosphamide + Docetaxel (or Paclitaxel)
  • Fayetteville, Arkansas
  • +1 more
Jan 26, 2023

Immune Response Trial in Oxford (Keyhole-Limpet Hemocyanin, Saline, Montanide ISA 51 VG)

Recruiting
  • Immune Response
  • Keyhole-Limpet Hemocyanin
  • +3 more
  • Oxford, United Kingdom
    NIHR Oxford Experimental Medicine Clinical Research Facility
May 16, 2023

Tumors, Esophageal Tumors, Esophagus Tumor Trial run by the National Cancer Institute (NCI) (Nivolumab, Entinostat, Montanide(R)

Not yet recruiting
  • Neoplasms
  • +5 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jun 16, 2023

NSCLC, Non-Small Cell Lung Carcinoma, NSCLC Trial run by the National Cancer Institute (NCI) (biological, drug, device)

Not yet recruiting
  • Non-Small Cell Lung Cancer
  • +3 more
  • Montanide (Registered Trademark) ISA-51 VG Adjuvant
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Tumors by Site, Metastatic Cancer Trial (P10s-PADRE)

Withdrawn
  • Neoplasms by Site
  • Metastatic Cancer
  • (no location specified)
Mar 15, 2021

Cancer, Tumor Trial in Frankfurt (NY-ESO-1b peptide plus CpG 7909 and Montanide® ISA-51)

Completed
Has Results
  • Cancer
  • Neoplasm
  • NY-ESO-1b peptide plus CpG 7909 and Montanide® ISA-51
  • Frankfurt, Germany
    Krankenhaus Nordwest
Oct 3, 2022

Advanced Head and Neck Squamous Cell Carcinoma, Lung Non-Small Cell Carcinoma, Metastatic Lung Non-Small Cell Carcinoma Trial in

Recruiting
  • Advanced Head and Neck Squamous Cell Carcinoma
  • +14 more
  • Laboratory Biomarker Analysis
  • +3 more
  • Indianapolis, Indiana
  • +4 more
Aug 19, 2022

Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in Philadelphia (OC-L/Montanide ISA 51 VG, Ampligen,

Terminated
Has Results
  • Ovarian Cancer
  • +2 more
  • OC-L/Montanide ISA 51 VG
  • +2 more
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Oct 18, 2021

Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in New York (NY-ESO-1 OLP4, NY-ESO-1 OLP4 +

Completed
Has Results
  • Epithelial Ovarian Cancer
  • +2 more
  • NY-ESO-1 OLP4
  • +2 more
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Oct 3, 2022

Unresectable or Metastatic Melanoma Trial in Australia, United States (Ipilimumab, NY-ESO-1 Protein Vaccine, NY-ESO-1 OLP4

Terminated
Has Results
  • Unresectable or Metastatic Melanoma
  • Ipilimumab
  • +3 more
  • New York, New York
  • +4 more
Oct 3, 2022

Primary Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in Philadelphia (OC-L, Montanide, poly-ICLC

Terminated
  • Primary Ovarian Cancer
  • +2 more
  • OC-L
  • +2 more
  • Philadelphia, Pennsylvania
    Ovarian Cancer Research Center
Apr 23, 2020

Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML), Chronic Myeloid Leukemia (CML) Trial run by the NHLBI

Completed
Has Results
  • Myelodysplastic Syndrome (MDS)
  • +2 more
  • WT1:126-134
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Jun 15, 2021

Intensive Care Unit Mobility Scale (IMS)

Recruiting
  • Muscle Weakness
  • +3 more
    • Berlin, Germany
      Charité - Univiversitätsmedizin Berlin
    Jan 28, 2023

    Primary Open-angle Glaucoma Trial in Maastricht (PRESERFLO Microshunt implantation, Trabeculectomy)

    Recruiting
    • Primary Open-angle Glaucoma
    • PRESERFLO Microshunt implantation
    • Trabeculectomy
    • Maastricht, Limburg, Netherlands
      Maastricht University Medical Center+ (MUMC+)
    Aug 16, 2022

    Peripheral Arterial Disease, Iliac Artery Stenosis, Embolus Arterial Trial in Warsaw (Iliac Stenting)

    Not yet recruiting
    • Peripheral Arterial Disease
    • +3 more
    • Iliac Stenting
    • Warsaw, Mazowieckie, Poland
      Medical Universtity of Warsaw
    May 16, 2022

    Muscle Weakness, Critical Illness Trial in Berlin (Device-assisted mobilisation with the sit/stand stabilizer Liana)

    Not yet recruiting
    • Muscle Weakness
    • Critical Illness
    • Device-assisted mobilisation with the sit/stand stabilizer Liana
    • Berlin, Germany
      Charité - Univiversitätsmedizin Berlin
    Feb 7, 2023